Bimodal distribution of azole susceptibility in Sporothrix brasiliensis isolates in Brazil

is an emerging zoonotic fungal pathogen that can be difficult to treat. Antifungal susceptibility testing was performed on the mold phase of a convenience sample of 61 spp. isolates from human and cat sporotrichosis cases in Brazil using the Clinical and Laboratory Standards Institute standard M38....

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Antimicrobial agents and chemotherapy 2024-04, Vol.68 (4), p.e0162023
Hauptverfasser: Ribeiro Dos Santos, Amanda, Gade, Lalitha, Misas, Elizabeth, Litvintseva, Anastasia P, Nunnally, Natalie S, Parnell, Lindsay A, Rajeev, Malavika, de Souza Carvalho Melhem, Marcia, Takahashi, Juliana Possato Fernandes, Oliboni, Gabriel Manzi, Bonfieti, Lucas Xavier, Araujo, Lisandra Siufi, Cappellano, Paola, Venturini, James, Lockhart, Shawn R, Sexton, D Joseph
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue 4
container_start_page e0162023
container_title Antimicrobial agents and chemotherapy
container_volume 68
creator Ribeiro Dos Santos, Amanda
Gade, Lalitha
Misas, Elizabeth
Litvintseva, Anastasia P
Nunnally, Natalie S
Parnell, Lindsay A
Rajeev, Malavika
de Souza Carvalho Melhem, Marcia
Takahashi, Juliana Possato Fernandes
Oliboni, Gabriel Manzi
Bonfieti, Lucas Xavier
Araujo, Lisandra Siufi
Cappellano, Paola
Venturini, James
Lockhart, Shawn R
Sexton, D Joseph
description is an emerging zoonotic fungal pathogen that can be difficult to treat. Antifungal susceptibility testing was performed on the mold phase of a convenience sample of 61 spp. isolates from human and cat sporotrichosis cases in Brazil using the Clinical and Laboratory Standards Institute standard M38. A bimodal distribution of azole susceptibility was observed with 50% (28/56) of isolates showing elevated itraconazole minimum inhibitory concentrations ≥16 µg/mL. Phylogenetic analysis found the resistant isolates were not clonal and were distributed across three different clades. Single nucleotide polymorphism (SNP) analysis was performed to identify potential mechanisms of resistance. Two of the 28 resistant isolates (MIC ≥16 mg/L) had a polymorphism in the cytochrome P450 gene, , corresponding to the well-known G448S substitution inducing azole resistance in . SNPs corresponding to other known mechanisms of azole resistance were not identified in the remaining 26 resistant isolates.
doi_str_mv 10.1128/aac.01620-23
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10989022</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2930472323</sourcerecordid><originalsourceid>FETCH-LOGICAL-a376t-2b2e88d69352be68352b0bce17e44245f8c2a734e9c97bff5b98aa1127167e0c3</originalsourceid><addsrcrecordid>eNp1kc1LxDAQxYMouq7ePEuPClbz0abJSVzxCwQP6sVLmHRTjaTNmqSi_vV23VX04GmYmR9vePMQ2iH4kBAqjgDqQ0w4xTllK2hEsBQ5LyVfRSOMOc8LgYsNtBnjMx76UuJ1tMEEE2WFyQg9TGzrp-CyqY0pWN0n67vMNxl8eGey2MfazJLV1tn0ntkuu5354NNTsG-ZDhCHuemijZmN3kEycc5MAnxYt4XWGnDRbC_rGN2fn92dXubXNxdXpyfXObCKp5xqaoSYcslKqg0X84J1bUhlioIWZSNqChUrjKxlpZum1FIADNYrwiuDazZGxwvdWa9bM61NlwI4NQu2hfCuPFj1d9PZJ_XoX9X8VRJTOijsLRWCf-lNTKq1g2_noDO-j4pKhouKMsoG9GCB1sHHGEzzc4dgNc9DDXmorzzUF76_wCG2VD37PnTDK_5jd3_7-BH-Dot9AqzMlY0</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2930472323</pqid></control><display><type>article</type><title>Bimodal distribution of azole susceptibility in Sporothrix brasiliensis isolates in Brazil</title><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><creator>Ribeiro Dos Santos, Amanda ; Gade, Lalitha ; Misas, Elizabeth ; Litvintseva, Anastasia P ; Nunnally, Natalie S ; Parnell, Lindsay A ; Rajeev, Malavika ; de Souza Carvalho Melhem, Marcia ; Takahashi, Juliana Possato Fernandes ; Oliboni, Gabriel Manzi ; Bonfieti, Lucas Xavier ; Araujo, Lisandra Siufi ; Cappellano, Paola ; Venturini, James ; Lockhart, Shawn R ; Sexton, D Joseph</creator><contributor>Krysan, Damian J.</contributor><creatorcontrib>Ribeiro Dos Santos, Amanda ; Gade, Lalitha ; Misas, Elizabeth ; Litvintseva, Anastasia P ; Nunnally, Natalie S ; Parnell, Lindsay A ; Rajeev, Malavika ; de Souza Carvalho Melhem, Marcia ; Takahashi, Juliana Possato Fernandes ; Oliboni, Gabriel Manzi ; Bonfieti, Lucas Xavier ; Araujo, Lisandra Siufi ; Cappellano, Paola ; Venturini, James ; Lockhart, Shawn R ; Sexton, D Joseph ; Krysan, Damian J.</creatorcontrib><description>is an emerging zoonotic fungal pathogen that can be difficult to treat. Antifungal susceptibility testing was performed on the mold phase of a convenience sample of 61 spp. isolates from human and cat sporotrichosis cases in Brazil using the Clinical and Laboratory Standards Institute standard M38. A bimodal distribution of azole susceptibility was observed with 50% (28/56) of isolates showing elevated itraconazole minimum inhibitory concentrations ≥16 µg/mL. Phylogenetic analysis found the resistant isolates were not clonal and were distributed across three different clades. Single nucleotide polymorphism (SNP) analysis was performed to identify potential mechanisms of resistance. Two of the 28 resistant isolates (MIC ≥16 mg/L) had a polymorphism in the cytochrome P450 gene, , corresponding to the well-known G448S substitution inducing azole resistance in . SNPs corresponding to other known mechanisms of azole resistance were not identified in the remaining 26 resistant isolates.</description><identifier>ISSN: 0066-4804</identifier><identifier>ISSN: 1098-6596</identifier><identifier>EISSN: 1098-6596</identifier><identifier>DOI: 10.1128/aac.01620-23</identifier><identifier>PMID: 38385701</identifier><language>eng</language><publisher>United States: American Society for Microbiology</publisher><subject>Antimicrobial Chemotherapy ; Susceptibility</subject><ispartof>Antimicrobial agents and chemotherapy, 2024-04, Vol.68 (4), p.e0162023</ispartof><rights>This is a work of the U.S. Government and is not subject to copyright protection in the United States. Foreign copyrights may apply.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-a376t-2b2e88d69352be68352b0bce17e44245f8c2a734e9c97bff5b98aa1127167e0c3</cites><orcidid>0000-0003-3099-7334 ; 0000-0002-2551-015X ; 0000-0002-5577-4498 ; 0000-0003-1086-8041 ; 0000-0002-4383-5994 ; 0000-0001-6243-7716</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10989022/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10989022/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,723,776,780,881,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38385701$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><contributor>Krysan, Damian J.</contributor><creatorcontrib>Ribeiro Dos Santos, Amanda</creatorcontrib><creatorcontrib>Gade, Lalitha</creatorcontrib><creatorcontrib>Misas, Elizabeth</creatorcontrib><creatorcontrib>Litvintseva, Anastasia P</creatorcontrib><creatorcontrib>Nunnally, Natalie S</creatorcontrib><creatorcontrib>Parnell, Lindsay A</creatorcontrib><creatorcontrib>Rajeev, Malavika</creatorcontrib><creatorcontrib>de Souza Carvalho Melhem, Marcia</creatorcontrib><creatorcontrib>Takahashi, Juliana Possato Fernandes</creatorcontrib><creatorcontrib>Oliboni, Gabriel Manzi</creatorcontrib><creatorcontrib>Bonfieti, Lucas Xavier</creatorcontrib><creatorcontrib>Araujo, Lisandra Siufi</creatorcontrib><creatorcontrib>Cappellano, Paola</creatorcontrib><creatorcontrib>Venturini, James</creatorcontrib><creatorcontrib>Lockhart, Shawn R</creatorcontrib><creatorcontrib>Sexton, D Joseph</creatorcontrib><title>Bimodal distribution of azole susceptibility in Sporothrix brasiliensis isolates in Brazil</title><title>Antimicrobial agents and chemotherapy</title><addtitle>Antimicrob Agents Chemother</addtitle><addtitle>Antimicrob Agents Chemother</addtitle><description>is an emerging zoonotic fungal pathogen that can be difficult to treat. Antifungal susceptibility testing was performed on the mold phase of a convenience sample of 61 spp. isolates from human and cat sporotrichosis cases in Brazil using the Clinical and Laboratory Standards Institute standard M38. A bimodal distribution of azole susceptibility was observed with 50% (28/56) of isolates showing elevated itraconazole minimum inhibitory concentrations ≥16 µg/mL. Phylogenetic analysis found the resistant isolates were not clonal and were distributed across three different clades. Single nucleotide polymorphism (SNP) analysis was performed to identify potential mechanisms of resistance. Two of the 28 resistant isolates (MIC ≥16 mg/L) had a polymorphism in the cytochrome P450 gene, , corresponding to the well-known G448S substitution inducing azole resistance in . SNPs corresponding to other known mechanisms of azole resistance were not identified in the remaining 26 resistant isolates.</description><subject>Antimicrobial Chemotherapy</subject><subject>Susceptibility</subject><issn>0066-4804</issn><issn>1098-6596</issn><issn>1098-6596</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNp1kc1LxDAQxYMouq7ePEuPClbz0abJSVzxCwQP6sVLmHRTjaTNmqSi_vV23VX04GmYmR9vePMQ2iH4kBAqjgDqQ0w4xTllK2hEsBQ5LyVfRSOMOc8LgYsNtBnjMx76UuJ1tMEEE2WFyQg9TGzrp-CyqY0pWN0n67vMNxl8eGey2MfazJLV1tn0ntkuu5354NNTsG-ZDhCHuemijZmN3kEycc5MAnxYt4XWGnDRbC_rGN2fn92dXubXNxdXpyfXObCKp5xqaoSYcslKqg0X84J1bUhlioIWZSNqChUrjKxlpZum1FIADNYrwiuDazZGxwvdWa9bM61NlwI4NQu2hfCuPFj1d9PZJ_XoX9X8VRJTOijsLRWCf-lNTKq1g2_noDO-j4pKhouKMsoG9GCB1sHHGEzzc4dgNc9DDXmorzzUF76_wCG2VD37PnTDK_5jd3_7-BH-Dot9AqzMlY0</recordid><startdate>20240403</startdate><enddate>20240403</enddate><creator>Ribeiro Dos Santos, Amanda</creator><creator>Gade, Lalitha</creator><creator>Misas, Elizabeth</creator><creator>Litvintseva, Anastasia P</creator><creator>Nunnally, Natalie S</creator><creator>Parnell, Lindsay A</creator><creator>Rajeev, Malavika</creator><creator>de Souza Carvalho Melhem, Marcia</creator><creator>Takahashi, Juliana Possato Fernandes</creator><creator>Oliboni, Gabriel Manzi</creator><creator>Bonfieti, Lucas Xavier</creator><creator>Araujo, Lisandra Siufi</creator><creator>Cappellano, Paola</creator><creator>Venturini, James</creator><creator>Lockhart, Shawn R</creator><creator>Sexton, D Joseph</creator><general>American Society for Microbiology</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0003-3099-7334</orcidid><orcidid>https://orcid.org/0000-0002-2551-015X</orcidid><orcidid>https://orcid.org/0000-0002-5577-4498</orcidid><orcidid>https://orcid.org/0000-0003-1086-8041</orcidid><orcidid>https://orcid.org/0000-0002-4383-5994</orcidid><orcidid>https://orcid.org/0000-0001-6243-7716</orcidid></search><sort><creationdate>20240403</creationdate><title>Bimodal distribution of azole susceptibility in Sporothrix brasiliensis isolates in Brazil</title><author>Ribeiro Dos Santos, Amanda ; Gade, Lalitha ; Misas, Elizabeth ; Litvintseva, Anastasia P ; Nunnally, Natalie S ; Parnell, Lindsay A ; Rajeev, Malavika ; de Souza Carvalho Melhem, Marcia ; Takahashi, Juliana Possato Fernandes ; Oliboni, Gabriel Manzi ; Bonfieti, Lucas Xavier ; Araujo, Lisandra Siufi ; Cappellano, Paola ; Venturini, James ; Lockhart, Shawn R ; Sexton, D Joseph</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a376t-2b2e88d69352be68352b0bce17e44245f8c2a734e9c97bff5b98aa1127167e0c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Antimicrobial Chemotherapy</topic><topic>Susceptibility</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ribeiro Dos Santos, Amanda</creatorcontrib><creatorcontrib>Gade, Lalitha</creatorcontrib><creatorcontrib>Misas, Elizabeth</creatorcontrib><creatorcontrib>Litvintseva, Anastasia P</creatorcontrib><creatorcontrib>Nunnally, Natalie S</creatorcontrib><creatorcontrib>Parnell, Lindsay A</creatorcontrib><creatorcontrib>Rajeev, Malavika</creatorcontrib><creatorcontrib>de Souza Carvalho Melhem, Marcia</creatorcontrib><creatorcontrib>Takahashi, Juliana Possato Fernandes</creatorcontrib><creatorcontrib>Oliboni, Gabriel Manzi</creatorcontrib><creatorcontrib>Bonfieti, Lucas Xavier</creatorcontrib><creatorcontrib>Araujo, Lisandra Siufi</creatorcontrib><creatorcontrib>Cappellano, Paola</creatorcontrib><creatorcontrib>Venturini, James</creatorcontrib><creatorcontrib>Lockhart, Shawn R</creatorcontrib><creatorcontrib>Sexton, D Joseph</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Antimicrobial agents and chemotherapy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ribeiro Dos Santos, Amanda</au><au>Gade, Lalitha</au><au>Misas, Elizabeth</au><au>Litvintseva, Anastasia P</au><au>Nunnally, Natalie S</au><au>Parnell, Lindsay A</au><au>Rajeev, Malavika</au><au>de Souza Carvalho Melhem, Marcia</au><au>Takahashi, Juliana Possato Fernandes</au><au>Oliboni, Gabriel Manzi</au><au>Bonfieti, Lucas Xavier</au><au>Araujo, Lisandra Siufi</au><au>Cappellano, Paola</au><au>Venturini, James</au><au>Lockhart, Shawn R</au><au>Sexton, D Joseph</au><au>Krysan, Damian J.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Bimodal distribution of azole susceptibility in Sporothrix brasiliensis isolates in Brazil</atitle><jtitle>Antimicrobial agents and chemotherapy</jtitle><stitle>Antimicrob Agents Chemother</stitle><addtitle>Antimicrob Agents Chemother</addtitle><date>2024-04-03</date><risdate>2024</risdate><volume>68</volume><issue>4</issue><spage>e0162023</spage><pages>e0162023-</pages><issn>0066-4804</issn><issn>1098-6596</issn><eissn>1098-6596</eissn><abstract>is an emerging zoonotic fungal pathogen that can be difficult to treat. Antifungal susceptibility testing was performed on the mold phase of a convenience sample of 61 spp. isolates from human and cat sporotrichosis cases in Brazil using the Clinical and Laboratory Standards Institute standard M38. A bimodal distribution of azole susceptibility was observed with 50% (28/56) of isolates showing elevated itraconazole minimum inhibitory concentrations ≥16 µg/mL. Phylogenetic analysis found the resistant isolates were not clonal and were distributed across three different clades. Single nucleotide polymorphism (SNP) analysis was performed to identify potential mechanisms of resistance. Two of the 28 resistant isolates (MIC ≥16 mg/L) had a polymorphism in the cytochrome P450 gene, , corresponding to the well-known G448S substitution inducing azole resistance in . SNPs corresponding to other known mechanisms of azole resistance were not identified in the remaining 26 resistant isolates.</abstract><cop>United States</cop><pub>American Society for Microbiology</pub><pmid>38385701</pmid><doi>10.1128/aac.01620-23</doi><tpages>8</tpages><orcidid>https://orcid.org/0000-0003-3099-7334</orcidid><orcidid>https://orcid.org/0000-0002-2551-015X</orcidid><orcidid>https://orcid.org/0000-0002-5577-4498</orcidid><orcidid>https://orcid.org/0000-0003-1086-8041</orcidid><orcidid>https://orcid.org/0000-0002-4383-5994</orcidid><orcidid>https://orcid.org/0000-0001-6243-7716</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0066-4804
ispartof Antimicrobial agents and chemotherapy, 2024-04, Vol.68 (4), p.e0162023
issn 0066-4804
1098-6596
1098-6596
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10989022
source Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central
subjects Antimicrobial Chemotherapy
Susceptibility
title Bimodal distribution of azole susceptibility in Sporothrix brasiliensis isolates in Brazil
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-11T04%3A32%3A55IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Bimodal%20distribution%20of%20azole%20susceptibility%20in%20Sporothrix%20brasiliensis%20isolates%20in%20Brazil&rft.jtitle=Antimicrobial%20agents%20and%20chemotherapy&rft.au=Ribeiro%20Dos%20Santos,%20Amanda&rft.date=2024-04-03&rft.volume=68&rft.issue=4&rft.spage=e0162023&rft.pages=e0162023-&rft.issn=0066-4804&rft.eissn=1098-6596&rft_id=info:doi/10.1128/aac.01620-23&rft_dat=%3Cproquest_pubme%3E2930472323%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2930472323&rft_id=info:pmid/38385701&rfr_iscdi=true